References
- Alps, B. J., Johnson, E. S., and Wilson, A. B., (1970). Cardiovascular actions of Wy-21901, a new hypotensive and antiarrhythmic agent. Brit. J. Pharmacol., 40, 151–-152P.1. Alps, B. J., Johnson, E. S., and Wilson, A. B., (1970). Cardiovascular actions of Wy-21901, a new hypotensive and antiarrhythmic agent. Brit. J. Pharmacol., 40, 151–-152P.
- Alps, B. J., Hill, M., Fidler, K., Johnson, E. S., and Wilson, A. B., (1971). The reversal of experimental cardiac arrhythmias by indoramin (Wy-21901). J. Pharm. Pharmac., 23, 678–686.2. Alps, B. J., Hill, M., Fidler, K., Johnson, E. S., and Wilson, A. B., (1971). The reversal of experimental cardiac arrhythmias by indoramin (Wy-21901). J. Pharm. Pharmac., 23, 678–686.
- Alps, B. J., Borrows, E. T., Johnson, E. S., Staniforth, M. W., and Wilson, A. B., (1972). A comparison of the cardiovascular actions of indoramin, propranolol, lignocaine and quinidine. Cardiovascular Res., 6, 226–234.3. Alps, B. J., Borrows, E. T., Johnson, E. S., Staniforth, M. W., and Wilson, A. B., (1972). A comparison of the cardiovascular actions of indoramin, propranolol, lignocaine and quinidine. Cardiovascular Res., 6, 226–234.
- Antani, J. A., and Srinivas, H. V., (1973). Further evaluation of phentolamine (Regitine) in cardiac arrhythmias. Curr. med. Res. Opin., 1, 494.4. Antani, J. A., and Srinivas, H. V., (1973). Further evaluation of phentolamine (Regitine) in cardiac arrhythmias. Curr. med. Res. Opin., 1, 494.
- Archibald, J. L., (1968). A new class of indole antihypertensive agents. Chimie Therapeutique, 3, 397.5. Archibald, J. L., (1968). A new class of indole antihypertensive agents. Chimie Therapeutique, 3, 397.
- Collis, M. g., and Alps, B. J., (1973). The evaluation of the alpha-adrenoceptor blocking action of indoramin, phentolamine and thymoxamine on the rat and guinea-pig isolated mesenteric vasculature and aortic spiral preparations. J. Pharm. Pharmac., 25, 621–628.6. Collis, M. g., and Alps, B. J., (1973). The evaluation of the alpha-adrenoceptor blocking action of indoramin, phentolamine and thymoxamine on the rat and guinea-pig isolated mesenteric vasculature and aortic spiral preparations. J. Pharm. Pharmac., 25, 621–628.
- Coltart, D. J., Lockhart, J. D. F., Royds, R. B., and Turner, P., (1971). Human pharmacology of indoramin. Brit. J. Pharmacol., 43, 467–468.7. Coltart, D. J., Lockhart, J. D. F., Royds, R. B., and Turner, P., (1971). Human pharmacology of indoramin. Brit. J. Pharmacol., 43, 467–468.
- Coltart, D. J., Meldrum, S. J., and Royds, R. B., (1971). Myocardial effects of indoramin hydrochloride, a new hypotensive agent. Brit. J. Pharmacol., 42, 664–665.8. Coltart, D. J., Meldrum, S. J., and Royds, R. B., (1971). Myocardial effects of indoramin hydrochloride, a new hypotensive agent. Brit. J. Pharmacol., 42, 664–665.
- Frohlich, E., Tarazi, R. C., Dustan, H. P., and Page, I. H., (1968). The paradox of beta-adrenergic blockade in hypertension. Circulation, 37, 317–423.9. Frohlich, E., Tarazi, R. C., Dustan, H. P., and Page, I. H., (1968). The paradox of beta-adrenergic blockade in hypertension. Circulation, 37, 317–423.
- Lewis, P. J., George, C. F., and Dollery, C. T., (1973). Clinical evaluation of indoramin, a new antihypertensive agent. Europ. J. clin. Pharmacol., 6, 211–216.10. Lewis, P. J., George, C. F., and Dollery, C. T., (1973). Clinical evaluation of indoramin, a new antihypertensive agent. Europ. J. clin. Pharmacol., 6, 211–216.
- Royds, R. B., Coltart, D. J., and Lockhart, J. D. F., (1972). Pharmacological studies of indoramin in man. Clin. Pharmacol. Ther., 13, 380–392.11. Royds, R. B., Coltart, D. J., and Lockhart, J. D. F., (1972). Pharmacological studies of indoramin in man. Clin. Pharmacol. Ther., 13, 380–392.